Cargando…

Comparison of LVAD Admissions Before and During the Era of COVID-19

PURPOSE: LVADs have improved survival and quality of life in advanced heart failure (HF) patients. However, post implant hospitalization rates remain higher than ideal, potentially impacting patient access and scarce resource utilization during COVID-19. This study examines the number of hospitaliza...

Descripción completa

Detalles Bibliográficos
Autores principales: George, S., Banayosy, A. M. El, Rendon, V.L., Jacob, T., Cunningham, L.C., Long, J.W., Horstmanshof, D.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988602/
http://dx.doi.org/10.1016/j.healun.2022.01.1446
_version_ 1784682998408413184
author George, S.
Banayosy, A. M. El
Rendon, V.L.
Jacob, T.
Cunningham, L.C.
Long, J.W.
Horstmanshof, D.A.
author_facet George, S.
Banayosy, A. M. El
Rendon, V.L.
Jacob, T.
Cunningham, L.C.
Long, J.W.
Horstmanshof, D.A.
author_sort George, S.
collection PubMed
description PURPOSE: LVADs have improved survival and quality of life in advanced heart failure (HF) patients. However, post implant hospitalization rates remain higher than ideal, potentially impacting patient access and scarce resource utilization during COVID-19. This study examines the number of hospitalizations, causes, and length of stay (LOS) during the COVID-19 era. METHODS: A retrospective review of 504 LVAD admissions from 9/2018 to 8/2021 was conducted. Admissions were divided into two-time periods each 18 months long: (a) Before COVID (9/2018 to 2/2020) and (b) during COVID (3/2020 to 8/2021). Admissions for cardiac transplantation were excluded. Admission rates (as events per patient-year, EPPY) were assessed as were the causes of admission with a 20% change (Delta, ∆) between eras considered clinically meaningful. RESULTS: A total of 153 patients were hospitalized with 504 total admissions. 274 (54.4%) were before COVID and 230 (45.6%) were during COVID. Overall LVAD admissions during the COVID era were lower (1.46 vs 1.63 admissions/patient-year, Table 1). During the COVID era, the risk of hospitalizations related to arrhythmias, device problems (low flow or device malfunction), and non-GI bleeding was increased by 60%, 40% and 21% respectively. At the same time, risk of admissions for gastrointestinal bleeding (GIB) and HF were lower by 20% and 33%, respectively. Average LOS between groups was not significantly different (p=0.21). CONCLUSION: Overall unplanned LVAD admission rates in the COVID era were decreased. Those admissions that could not readily be managed in the outpatient domain for arrhythmias, device problems, and bleeding (non-GIB) were higher. However, GI bleeding (GIB) and heart failure (HF) hospitalizations were lower in the COVID era, likely related to extraordinary efforts to manage such adverse events in the outpatient setting or due to patient behavior changes during periods of quarantine. Other explanations appear less likely given that device use and outpatient management were similar between these 2 eras.
format Online
Article
Text
id pubmed-8988602
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89886022022-04-11 Comparison of LVAD Admissions Before and During the Era of COVID-19 George, S. Banayosy, A. M. El Rendon, V.L. Jacob, T. Cunningham, L.C. Long, J.W. Horstmanshof, D.A. J Heart Lung Transplant (867) PURPOSE: LVADs have improved survival and quality of life in advanced heart failure (HF) patients. However, post implant hospitalization rates remain higher than ideal, potentially impacting patient access and scarce resource utilization during COVID-19. This study examines the number of hospitalizations, causes, and length of stay (LOS) during the COVID-19 era. METHODS: A retrospective review of 504 LVAD admissions from 9/2018 to 8/2021 was conducted. Admissions were divided into two-time periods each 18 months long: (a) Before COVID (9/2018 to 2/2020) and (b) during COVID (3/2020 to 8/2021). Admissions for cardiac transplantation were excluded. Admission rates (as events per patient-year, EPPY) were assessed as were the causes of admission with a 20% change (Delta, ∆) between eras considered clinically meaningful. RESULTS: A total of 153 patients were hospitalized with 504 total admissions. 274 (54.4%) were before COVID and 230 (45.6%) were during COVID. Overall LVAD admissions during the COVID era were lower (1.46 vs 1.63 admissions/patient-year, Table 1). During the COVID era, the risk of hospitalizations related to arrhythmias, device problems (low flow or device malfunction), and non-GI bleeding was increased by 60%, 40% and 21% respectively. At the same time, risk of admissions for gastrointestinal bleeding (GIB) and HF were lower by 20% and 33%, respectively. Average LOS between groups was not significantly different (p=0.21). CONCLUSION: Overall unplanned LVAD admission rates in the COVID era were decreased. Those admissions that could not readily be managed in the outpatient domain for arrhythmias, device problems, and bleeding (non-GIB) were higher. However, GI bleeding (GIB) and heart failure (HF) hospitalizations were lower in the COVID era, likely related to extraordinary efforts to manage such adverse events in the outpatient setting or due to patient behavior changes during periods of quarantine. Other explanations appear less likely given that device use and outpatient management were similar between these 2 eras. Published by Elsevier Inc. 2022-04 2022-04-07 /pmc/articles/PMC8988602/ http://dx.doi.org/10.1016/j.healun.2022.01.1446 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle (867)
George, S.
Banayosy, A. M. El
Rendon, V.L.
Jacob, T.
Cunningham, L.C.
Long, J.W.
Horstmanshof, D.A.
Comparison of LVAD Admissions Before and During the Era of COVID-19
title Comparison of LVAD Admissions Before and During the Era of COVID-19
title_full Comparison of LVAD Admissions Before and During the Era of COVID-19
title_fullStr Comparison of LVAD Admissions Before and During the Era of COVID-19
title_full_unstemmed Comparison of LVAD Admissions Before and During the Era of COVID-19
title_short Comparison of LVAD Admissions Before and During the Era of COVID-19
title_sort comparison of lvad admissions before and during the era of covid-19
topic (867)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988602/
http://dx.doi.org/10.1016/j.healun.2022.01.1446
work_keys_str_mv AT georges comparisonoflvadadmissionsbeforeandduringtheeraofcovid19
AT banayosyamel comparisonoflvadadmissionsbeforeandduringtheeraofcovid19
AT rendonvl comparisonoflvadadmissionsbeforeandduringtheeraofcovid19
AT jacobt comparisonoflvadadmissionsbeforeandduringtheeraofcovid19
AT cunninghamlc comparisonoflvadadmissionsbeforeandduringtheeraofcovid19
AT longjw comparisonoflvadadmissionsbeforeandduringtheeraofcovid19
AT horstmanshofda comparisonoflvadadmissionsbeforeandduringtheeraofcovid19